Progress 07/15/16 to 03/14/18
Outputs Target Audience:Dr. Erik Jensen,the project PI,met with researchers at the USDA Western Regional Research Center in Albany, CAto discuss the objectives and results of our Phase I effort. Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?
Nothing Reported
How have the results been disseminated to communities of interest?
Nothing Reported
What do you plan to do during the next reporting period to accomplish the goals?
Nothing Reported
Impacts What was accomplished under these goals?
In our successful SBIR Phase I effort, we have established the technical feasibility of our patented valveless fluidic switching (VLFS) microfluidic automation technology to perform rapid detection of 1 colony forming unit (cfu) of pathogenic E. coli O157:H7 in 25g food samples with an overall sample processing and analysis time of 6 hours. Specifically, we have adapted a commercial immunomagnetic separation (IMS) kit (Dynabeads anti-E. coli O157, Thermofisher Scientific) to our portable microfluidic automation platform and developed a miniaturized qPCR system for isolation and detection of E. coli O157. Both the microfluidic IMS and qPCR have been demonstrated to have equivalent performance to their respective manually performed benchtop procedures. As such, we have achieved the overall Phase I goal of demonstrating microfluidic automation of rapid foodborne pathogen detection by accomplishing each of the following four technical objectives: 1) We have demonstrated rapid detection of E. coli O157:H7 in phosphate buffered saline (PBS) using our VLFS based microfluidic IMS and qPCR platform with comparable results to manually performed benchtop methods. The manual and automated IMS procedures resulted in comparable % recoveries (23% and 32%, respectively), which are both similar to those found in literature. In addition to the automated cell purification procedure, we developed a method for automated thermal lysis of cells during the IMS procedure to isolate genetic material from the magnetic beads which are inhibitory to the microfluidic qPCR. To compare our microfluidic qPCR with the performance of a MX3005p commercial qPCR platform, we tested samples ranging between 1000 and 10 copies of E. coli O157 genomic DNA and negative controls. Our microfluidic qPCR has identical performance for limit of detection and improved performance for amplification efficiency. 2) We have demonstrated rapid detection of E. coli O157 in real food samples by using beef spiked with E. coli O157:H7 and automated sample loading of enrichment media. Specifically, we are able to detect 10 E. coli O157 cells spiked onto 25 g beef samples with a 5 hour 10 minute overall time to result, corresponding to a ~6 hour time to result for 1 cfu/25g sample. Our novel, automated loading technology enables direct transfer of enrichment broth to the pathogen detection platform without any pipetting steps. 3) We have evaluated the use of aptamers as capturing agents for possible improvements in assay performance compared to antibody based capturing agents. However, the results suggest that antibodies have better assay performances than aptamers. 4) Based on the results of Phase I, we have designed a Phase II microfluidic device and prototype instrument capable of automating each of the following steps: Sample loading, IMS, elution/cell lysis, mastermix preparation, and qPCR analysis. In addition, the Phase II prototype is designed to perform analysis of three enriched samples simultaneously, and is capable of detecting multiple foodborne pathogens. As such, the completion of the above objectives demonstrates the technical feasibility of rapid, automated, portable foodborne pathogen detection using our VLFS and miniaturized qPCR technology with sensitivity and specificity only currently achievable with laboratory-based instruments.
Publications
|